1.A double blind randomized controlled trial using topical application of travoprost 0.004% (40 µg/ml) vs placebo to induce hair growth among healthy male volunteers with androgenetic alopecia.
Bernardo Emiliano M. ; Ganzon-Bernardo Jennifer Grendel ; Adarlo Genejane M ; Mallari Maria Rica S.
Journal of the Philippine Dermatological Society 2005;14(1):11-16
BACKGROUND: Androgenetic alopecia (AGA) is the most common type of hair loss affecting men. Prostaglandin analogues are a new class of antiglaucoma agents documented to have localized and possibly permanent hair growth
OBJECTIVE:To obtain quantitative evidence of the hair-inducing properties of travoprost (0.004%) vs a placebo
METHODS: Included are twenty healthy male subjects with male pattern baldness types III to VII based on the Hamilton Norwood Scale for pattern of hair loss. Participants applied the substances onto the test sites of the scalp twice daily. Baseline photos and bimonthly photographs were taken. Hair growth was evaluated during each follow-up in terms of hair density and hair type and manual hair count was done. Repeated measure analysis was performed with a level of significance set at 0.05
RESULTS: After 8 weeks of treatment, there was no significant difference in total hair density between the travoprost and the placebo groups (p=0.49). No significant difference was demonstrated in the number of vellus, intermediate and terminal hair at different follow-up periods using travoprost and placebo(p=0.66, p=0.86, p=0.89)
CONCLUSION: The use of topical travoprost 40 mg/ml did not induce statistically significant hair growth in the bald scalps of human subjects.
Human ; Male ; Middle Aged ; Adult ; Alopecia ; Hair ; Prostaglandins, Synthetic ; Scalp ; Travoprost
2.Use of eye care services among type 2 diabetic patients in Laguna.
Glenn Carandang ; Maria Victoria Rondaris ; Genejane Adarlo
Philippine Journal of Ophthalmology 2016;41(2):39-44
OBJECTIVE: The aim of the study was to determine the prevalence of diabetic patients seeking an ophthalmic evaluation for diabetic retinopathy. Specific objectives were to describe the prevalence and risk factors for diabetic retinopathy (DR) in a group of diabetic patients referred for retinal evaluation from different internists in Laguna by screening using digital retinal photography.
METHODS: The study was a hospital-based mixed method study involving two portions: quantitative (cross-sectional) and qualitative. The cross-sectional portion involved patients diagnosed with type 2 diabetes by internists from San Pablo Colleges Medical Center referred for retinal evaluation using a non-mydriatic retinal camera. Retinal photographs were categorised for the presence and severity of diabetic retinopathy according to the international clinical DR severity scales recommended by the Global Diabetic Retinopathy Project Group. The qualitative portion involved a focus group discussion among diabetic patients and a short key informant interview with the referring internists.
RESULTS: Sixty-seven (67) diabetic patients were evaluated for diabetic retinopathy (DR) using digital retinal photography. The overall prevalence of any DR was 26% (n=18): 55% mild NDPR, 33% moderate NDPR, 6% severe NPDR and 6% PDR. Diabetic macular edema (DME) was present in 22% of patients with any form of DR. The focus group discussion reported the following reasons for consulting an ophthalmologist: presence of blurring of vision, availability of budget, knowledge of the need for ophthalmic evaluation, and order for evaluation by the internist. Interviews among the referring internists revealed three primary reasons for referring: history of visual disturbances, uncontrolled diabetes and finances of the patient.
CONCLUSION: This study presented a lower prevalence rate of diabetic retinopathy among patients who underwent digital retinal photography compared to that of other studies published in the Philippines. Nevertheless, it is important to continue patient education with regards to diabetic complications in the eye, and improve the referral system among medical practitioners.
Human ; Male ; Female ; Aged 80 And Over ; Aged ; Middle Aged ; Adult ; Diabetic Retinopathy ; Diabetes Mellitus, Type 2 ; Macular Edema ; Prevalence ; Ophthalmologists ; Retina
3.Why do graphic health warnings fail: An explanatory case study on the persistence of smoking behavior among male adult smokers in a rural and low-income setting in the Philippines.
John Rafael Arda ; Ashley Gabrielle Jeanjaquet ; Navin John Pasia ; John Dominic Mari Rafael ; Danyz Samantha Rita ; Kaye Bernice Siao ; Jecelyn Grace Yparraguirre ; Genejane Adarlo
Philippine Journal of Allied Health Sciences 2021;5(1):94-101
BACKGROUND:
The Philippines enacted in 2014 Republic Act No. 10643 that mandated the printing of Graphic Health Warnings on tobacco packages. However, smoking behavior among male smokers in the country, particularly in rural and low-income areas, persists even if the Graphic Health Warnings are according to the guidelines set by the World Health Organization. Hence, this explanatory case study aims to examine why and how most male adult smokers in a rural and low-income setting in the Philippines fail to quit smoking despite the presence of Graphic Health Warnings on tobacco packages.
METHODS:
Forty-four male adult smokers from Barangay Urdaneta in Magallanes, Cavite, were recruited to participate in this study through snowball sampling. They underwent semi-structured interviews about their history of smoking, experiences as a smoker, and perspectives on Graphic Health Warnings. Thematic analysis of verbatim transcripts was then carried out to identify emerging themes.
RESULTS:
Findings showed Graphic Health Warnings fail to persuade against smoking because fear was not aroused enough for smoking cessation. Specifically, the perception of risk from smoking was low due to lack of literacy on its harmful effects, and self-efficacy needed for smoking cessation was low because of self-doubt and denial. Other factors, such as the subjective and social benefits of smoking, were likewise contributory to the persistence of smoking behavior.
CONCLUSION
All these concerns must be considered for an effective campaign against tobacco use and consumption since Graphic Health Warnings on tobacco packages is only one strategy to address the burden of tobacco smoking.